Ratings ASGN Incorporated

Equities

ASGN

US00191U1025

Real-time Estimate Cboe BZX Other stock markets 01:18:20 2024-04-18 pm EDT			5-day change	1st Jan Change
95.42 ^USD	+0.72%		-0.44%	-0.09%

Mar. 26	ASGN Unit Wins $120 Million Cybersecurity Contract With Centers for Medicare and Medicaid Services	MT
Mar. 08	Asgn Insider Sold Shares Worth $7,488,088, According to a Recent SEC Filing	MT

Summary

Overall, and from a short-term perspective, the company presents an interesting fundamental situation.
The company has a good ESG score relative to its sector, according to Refinitiv.

Strengths

There is high visibility into the group's activities for the coming years. Outlooks on future revenues from analysts covering the equity remain similar. Such hardly dispersed estimates support highly predictable sales for the current and upcoming fiscal years.
The group usually releases upbeat results with huge surprise rates.

Weaknesses

According to forecast, a sluggish sales growth is expected for the next fiscal years.
For the last twelve months, the trend in sales revisions has been clearly going down, which emphasizes downgraded expectations from the analysts.
The overall consensus opinion of analysts has deteriorated sharply over the past four months.

Ratings chart - Surperformance

Chart ESG Refinitiv

Sector: IT Services & Consulting

	1st Jan change	Capi.	ESG Refinitiv
ASGN INCORPORATED	-0.09%	4.4B	B+
ACCENTURE PLC	-9.92%	198B	A-
IBM	+11.16%	168B	B-
TATA CONSULTANCY SERVICES LTD.	+1.81%	167B	B+
AUTOMATIC DATA PROCESSING, INC.	+4.30%	99.78B	A-
RELX PLC	+7.04%	77.01B	A-
CROWDSTRIKE HOLDINGS, INC.	+15.93%	71.03B	C-
INFOSYS LIMITED	-8.01%	69.99B	A
SNOWFLAKE INC.	-24.67%	49.69B	C
HCL TECHNOLOGIES LIMITED	+0.05%	47.82B	A-

Investor Rating

Trading Rating

ESG Refinitiv

Financials

Sales growth

Earnings Growth

EBITDA / Sales

Profitability

Finances

Valuation

P/E ratio

EV / Sales

Price to Book

Price to Free Cash Flow

Yield

Momentum

1 year Revenue revision

4 months Revenue revision

7 days Revenue revision

1 year EPS revision

4 months EPS revision

Consensus

Analyst Opinion

Potential Price Target

4m Target Price Revision

4m Revision of opinion

12m Revision of opinion

Business Predictability

Analyst Coverage

Divergence of Estimates

Divergence of analysts' opinions

Divergence of Target Price

Earnings quality

Environment

Emissions

Innovation

Use of resources

Governance

CSR Strategy

Management

Shareholders

Controversy

Technical analysis

ST Timing

MT Timing

LT Timing

RSI

Bollinger Spread

Unusual volumes